BioCryst Pharmaceuticals
BCRX
$4.16
Share price
0.00%
Change (1 day)
-45.34%
Change (1 year)
Categories
Number of shares outstanding for BioCryst Pharmaceuticals (BCRX)
Number of shares outstanding as of April 2024 : 189,644,000
According to BioCryst Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 189,644,000. At the end of 2023 the company had 189,644,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for BioCryst Pharmaceuticals from 2001 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.18 B | 1.46% |
| 2022 | 0.18 B | 2.79% |
| 2021 | 0.18 B | 2.96% |
| 2020 | 0.17 B | 34.51% |
| 2019 | 0.13 B | 19.58% |
| 2018 | 0.10 B | 11.59% |
| 2017 | 98.4 M | 33.4% |
| 2016 | 73.76 M | 0.57% |
| 2015 | 73.34 M | 2.06% |
| 2014 | 71.86 M | 21.62% |
| 2013 | 59.09 M | 16.13% |
| 2012 | 50.88 M | 12.63% |
| 2011 | 45.17 M | 0.66% |
| 2010 | 44.88 M | 16.7% |
| 2009 | 38.46 M | 0.96% |
| 2008 | 38.09 M | 11.14% |
| 2007 | 34.27 M | 17.3% |
| 2006 | 29.22 M | 11.5% |
| 2005 | 26.2 M | 20.75% |
| 2004 | 21.7 M | 22.74% |
| 2003 | 17.68 M | 0.2% |
| 2002 | 17.65 M | 0.48% |
| 2001 | 17.56 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | 1,248,000,000 | 558.08% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,028,000,000 | 969.37% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | 88,889,000 | -53.13% | 🇺🇸 USA |
 Repligen
RGEN | 55,815,666 | -70.57% | 🇺🇸 USA |
 Novavax NVAX | 103,429,000 | -45.46% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 47,261,000 | -75.08% | 🇺🇸 USA |
 NanoViricides NNVC | 11,745,906 | -93.81% | 🇺🇸 USA |
 Cel-Sci
CVM | 48,470,600 | -74.44% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 51,800,000 | -72.69% | 🇺🇸 USA |